
Maris R. Kessel
Examiner (ID: 14775, Phone: (571)270-7698 , Office: P/1759 )
| Most Active Art Unit | 1759 |
| Art Unit(s) | 1795, 1759, 1758, 1699 |
| Total Applications | 485 |
| Issued Applications | 239 |
| Pending Applications | 11 |
| Abandoned Applications | 232 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12565845
[patent_doc_number] => 10017522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Alpha helix mimetics and methods relating thereto
[patent_app_type] => utility
[patent_app_number] => 14/720690
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 43444
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14720690
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/720690 | Alpha helix mimetics and methods relating thereto | May 21, 2015 | Issued |
Array
(
[id] => 12448248
[patent_doc_number] => 09981934
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Enzyme-specific fluorescent compound capable of being retained in cells
[patent_app_type] => utility
[patent_app_number] => 15/310641
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 10391
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310641
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310641 | Enzyme-specific fluorescent compound capable of being retained in cells | May 12, 2015 | Issued |
Array
(
[id] => 14761993
[patent_doc_number] => 10392381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Prevention and treatment of non-alcoholic fatty liver disease
[patent_app_type] => utility
[patent_app_number] => 15/326771
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23445
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326771
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326771 | Prevention and treatment of non-alcoholic fatty liver disease | May 5, 2015 | Issued |
Array
(
[id] => 10422442
[patent_doc_number] => 20150307453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'NOVEL QUINOLINE DERIVATIVES AND THEIR APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/703769
[patent_app_country] => US
[patent_app_date] => 2015-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16713
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14703769
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/703769 | Quinoline derivatives and their applications | May 3, 2015 | Issued |
Array
(
[id] => 11497717
[patent_doc_number] => 20170071902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'NOX INHIBITOR AND NFkB INHIBITOR CONTAINING METHOXYFLAVONE'
[patent_app_type] => utility
[patent_app_number] => 15/308868
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10168
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308868
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308868 | NOX INHIBITOR AND NFkB INHIBITOR CONTAINING METHOXYFLAVONE | Apr 30, 2015 | Abandoned |
Array
(
[id] => 11487000
[patent_doc_number] => 09593064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-14
[patent_title] => 'Conversion of alcohols to alkyl esters and carboxylic acids using heterogeneous palladium-based catalysts'
[patent_app_type] => utility
[patent_app_number] => 14/702266
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 32
[patent_no_of_words] => 17619
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14702266
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/702266 | Conversion of alcohols to alkyl esters and carboxylic acids using heterogeneous palladium-based catalysts | Apr 30, 2015 | Issued |
Array
(
[id] => 11455790
[patent_doc_number] => 20170049697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'MEMBRANE-ADHERENT SELF-ASSEMBLED SYSTEMS FOR TREATMENT OF OCULAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/308000
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11274
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308000
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308000 | Membrane-adherent self-assembled system for treatment of ocular disorders | Apr 30, 2015 | Issued |
Array
(
[id] => 12192758
[patent_doc_number] => 09896477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => 'Limonin extraction method'
[patent_app_type] => utility
[patent_app_number] => 15/302983
[patent_app_country] => US
[patent_app_date] => 2015-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2281
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15302983
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/302983 | Limonin extraction method | Apr 29, 2015 | Issued |
Array
(
[id] => 15816389
[patent_doc_number] => 10633360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Efficient process for the synthesis of alkoxy substituted benzaldehydes
[patent_app_type] => utility
[patent_app_number] => 15/538012
[patent_app_country] => US
[patent_app_date] => 2015-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5686
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 423
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/538012 | Efficient process for the synthesis of alkoxy substituted benzaldehydes | Apr 28, 2015 | Issued |
Array
(
[id] => 11542583
[patent_doc_number] => 20170096407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'CATALYST RECYCLE METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/308989
[patent_app_country] => US
[patent_app_date] => 2015-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17890
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308989
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308989 | Catalyst recycle methods | Apr 28, 2015 | Issued |
Array
(
[id] => 10340405
[patent_doc_number] => 20150225411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/697236
[patent_app_country] => US
[patent_app_date] => 2015-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42783
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14697236
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/697236 | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors | Apr 26, 2015 | Issued |
Array
(
[id] => 11794047
[patent_doc_number] => 09403797
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => '5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 14/693307
[patent_app_country] => US
[patent_app_date] => 2015-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 25682
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14693307
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/693307 | 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use | Apr 21, 2015 | Issued |
Array
(
[id] => 11767878
[patent_doc_number] => 09376454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Beta-lactamase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/693318
[patent_app_country] => US
[patent_app_date] => 2015-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49809
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14693318
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/693318 | Beta-lactamase inhibitors | Apr 21, 2015 | Issued |
Array
(
[id] => 11275955
[patent_doc_number] => 09492425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Crystalline forms of genistein'
[patent_app_type] => utility
[patent_app_number] => 14/691251
[patent_app_country] => US
[patent_app_date] => 2015-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 18131
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14691251
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/691251 | Crystalline forms of genistein | Apr 19, 2015 | Issued |
Array
(
[id] => 14295003
[patent_doc_number] => 10287619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Measurement method for dehydrogenase and substrate concentration thereof, electron mediator, and measurement reagent for dehydrogenase including said electron mediator and for substrate thereof
[patent_app_type] => utility
[patent_app_number] => 15/304710
[patent_app_country] => US
[patent_app_date] => 2015-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 3791
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304710 | Measurement method for dehydrogenase and substrate concentration thereof, electron mediator, and measurement reagent for dehydrogenase including said electron mediator and for substrate thereof | Apr 16, 2015 | Issued |
Array
(
[id] => 11098888
[patent_doc_number] => 20160295858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'ANTIMICROBIAL ARTICLES AND COMPOUNDS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/680689
[patent_app_country] => US
[patent_app_date] => 2015-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10831
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14680689
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/680689 | Water stable antimicrobial silanol quaternary ammonium compounds | Apr 6, 2015 | Issued |
Array
(
[id] => 13026331
[patent_doc_number] => 10035781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Process for producing ethylene oxide
[patent_app_type] => utility
[patent_app_number] => 15/300637
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7647
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300637
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/300637 | Process for producing ethylene oxide | Mar 30, 2015 | Issued |
Array
(
[id] => 10705421
[patent_doc_number] => 20160051568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'CYCLODEXTRIN AND BUDESONIDE DERIVATIVE COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/672831
[patent_app_country] => US
[patent_app_date] => 2015-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13532
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14672831
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/672831 | Cyclodextrin and budesonide derivative compositions and methods | Mar 29, 2015 | Issued |
Array
(
[id] => 14700021
[patent_doc_number] => 10377744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Potent soluble epdxide hydrolase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/128933
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 19740
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15128933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/128933 | Potent soluble epdxide hydrolase inhibitors | Mar 26, 2015 | Issued |
Array
(
[id] => 10671285
[patent_doc_number] => 20160017431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'Methods for Predicting EGFR Tyrosine Kinase Inhibitor Efficacy'
[patent_app_type] => utility
[patent_app_number] => 14/671213
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14865
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671213
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/671213 | Methods for Predicting EGFR Tyrosine Kinase Inhibitor Efficacy | Mar 26, 2015 | Abandoned |